AUD 0.07
(-4.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 8.03 Million AUD | 105.73% |
2023 | 3.9 Million AUD | -25.65% |
2022 | 5.25 Million AUD | -46.95% |
2021 | 9.9 Million AUD | 4.76% |
2020 | 9.45 Million AUD | -0.52% |
2019 | 9.5 Million AUD | 139.72% |
2018 | 3.96 Million AUD | 29.36% |
2017 | 3.06 Million AUD | -8.02% |
2016 | 3.33 Million AUD | -40.42% |
2015 | 5.59 Million AUD | -47.15% |
2014 | 10.57 Million AUD | 81.47% |
2013 | 5.82 Million AUD | 1.95% |
2012 | 5.71 Million AUD | -17.08% |
2011 | 6.89 Million AUD | 11.18% |
2010 | 6.2 Million AUD | -9.22% |
2009 | 6.83 Million AUD | -37.76% |
2008 | 10.97 Million AUD | 101.34% |
2007 | 5.45 Million AUD | 630.15% |
2006 | 746.83 Thousand AUD | 0.63% |
2005 | 742.18 Thousand AUD | -11.0% |
2004 | 833.9 Thousand AUD | -78.63% |
2003 | 3.9 Million AUD | -53.53% |
2002 | 8.39 Million AUD | 3458.9% |
2001 | 236 Thousand AUD | 104.04% |
2000 | -5.84 Million AUD | -225.41% |
1999 | -1.79 Million AUD | -151.51% |
1998 | -714.42 Thousand AUD | -148.14% |
1997 | 1.48 Million AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.75 Million AUD | 0.0% |
2024 FY | 7.49 Million AUD | 91.97% |
2024 Q4 | 4.27 Million AUD | 0.0% |
2023 Q2 | 1.97 Million AUD | 0.0% |
2023 Q4 | 1.93 Million AUD | 0.0% |
2023 FY | 3.9 Million AUD | -25.65% |
2022 Q2 | 2.74 Million AUD | 0.0% |
2022 FY | 5.25 Million AUD | -46.95% |
2022 Q4 | 2.68 Million AUD | 0.0% |
2021 Q4 | 3.6 Million AUD | 0.0% |
2021 Q2 | 6.34 Million AUD | 0.0% |
2021 FY | 9.9 Million AUD | 4.76% |
2020 FY | 9.45 Million AUD | -0.52% |
2020 Q2 | 3.57 Million AUD | 0.0% |
2020 Q4 | 5.88 Million AUD | 0.0% |
2019 FY | 9.5 Million AUD | 139.72% |
2019 Q4 | 4.34 Million AUD | 0.0% |
2019 Q2 | 4.13 Million AUD | 0.0% |
2018 FY | 3.96 Million AUD | 29.36% |
2018 Q2 | 1.65 Million AUD | 0.0% |
2018 Q4 | 2.42 Million AUD | 0.0% |
2017 Q2 | 1.87 Million AUD | 0.0% |
2017 Q4 | 1.48 Million AUD | 0.0% |
2017 FY | 3.06 Million AUD | -8.02% |
2016 Q4 | 1.65 Million AUD | 0.0% |
2016 Q2 | 1.67 Million AUD | 0.0% |
2016 FY | 3.33 Million AUD | -40.42% |
2015 Q4 | 2.52 Million AUD | 0.0% |
2015 FY | 5.59 Million AUD | -47.15% |
2015 Q2 | 3.06 Million AUD | 0.0% |
2014 Q2 | 7.3 Million AUD | 0.0% |
2014 FY | 10.57 Million AUD | 81.47% |
2014 Q4 | 3.27 Million AUD | 0.0% |
2013 Q2 | 2.85 Million AUD | 2081.43% |
2013 Q1 | 130.8 Thousand AUD | 0.0% |
2013 FY | 5.82 Million AUD | 1.95% |
2013 Q4 | 2.97 Million AUD | 1954.13% |
2013 Q3 | 144.9 Thousand AUD | -94.92% |
2012 Q4 | - AUD | -100.0% |
2012 FY | 5.71 Million AUD | -17.08% |
2012 Q2 | 130.8 Thousand AUD | -59.33% |
2012 Q3 | 130.8 Thousand AUD | 0.0% |
2012 Q1 | 321.62 Thousand AUD | 0.0% |
2011 Q2 | 321.62 Thousand AUD | -17.76% |
2011 Q1 | 391.1 Thousand AUD | 0.0% |
2011 FY | 6.89 Million AUD | 11.18% |
2011 Q4 | - AUD | -100.0% |
2011 Q3 | 321.62 Thousand AUD | 0.0% |
2010 Q4 | - AUD | -100.0% |
2010 Q3 | 391.1 Thousand AUD | 0.0% |
2010 Q1 | 138.56 Thousand AUD | 0.0% |
2010 Q2 | 391.1 Thousand AUD | 182.26% |
2010 FY | 6.2 Million AUD | -9.22% |
2009 Q3 | 138.56 Thousand AUD | 0.0% |
2009 Q2 | 138.56 Thousand AUD | -28.45% |
2009 Q4 | - AUD | -100.0% |
2009 FY | 6.83 Million AUD | -37.76% |
2009 Q1 | 193.66 Thousand AUD | 0.0% |
2008 Q2 | 193.66 Thousand AUD | 109.15% |
2008 Q4 | - AUD | -100.0% |
2008 FY | 10.97 Million AUD | 101.34% |
2008 Q1 | 92.59 Thousand AUD | 0.0% |
2008 Q3 | 193.66 Thousand AUD | 0.0% |
2007 Q1 | 123.63 Thousand AUD | 0.0% |
2007 FY | 5.45 Million AUD | 630.15% |
2007 Q4 | - AUD | -100.0% |
2007 Q3 | 92.59 Thousand AUD | 0.0% |
2007 Q2 | 92.59 Thousand AUD | -25.11% |
2006 Q3 | 123.63 Thousand AUD | 0.0% |
2006 Q2 | 123.63 Thousand AUD | -16.21% |
2006 FY | 746.83 Thousand AUD | 0.63% |
2006 Q4 | - AUD | -100.0% |
2006 Q1 | 147.55 Thousand AUD | 0.0% |
2005 FY | 742.18 Thousand AUD | -11.0% |
2005 Q3 | 147.55 Thousand AUD | 0.0% |
2005 Q2 | 147.55 Thousand AUD | -20.06% |
2005 Q1 | 184.58 Thousand AUD | 0.0% |
2005 Q4 | - AUD | -100.0% |
2004 Q1 | 346.73 Thousand AUD | 0.0% |
2004 Q2 | 184.58 Thousand AUD | -46.76% |
2004 Q3 | 184.58 Thousand AUD | 0.0% |
2004 Q4 | - AUD | -100.0% |
2004 FY | 833.9 Thousand AUD | -78.63% |
2003 Q4 | - AUD | -100.0% |
2003 Q1 | 1.03 Million AUD | 0.0% |
2003 Q2 | 346.73 Thousand AUD | -66.4% |
2003 Q3 | 346.73 Thousand AUD | 0.0% |
2003 FY | 3.9 Million AUD | -53.53% |
2002 Q3 | 1.03 Million AUD | 0.0% |
2002 Q1 | 657.5 Thousand AUD | 0.0% |
2002 Q4 | - AUD | -100.0% |
2002 Q2 | 1.03 Million AUD | 56.94% |
2002 FY | 8.39 Million AUD | 3458.9% |
2001 Q1 | -2.99 Million AUD | 0.0% |
2001 Q4 | - AUD | -100.0% |
2001 Q3 | 657.5 Thousand AUD | 0.0% |
2001 Q2 | 657.5 Thousand AUD | 121.99% |
2001 FY | 236 Thousand AUD | 104.04% |
2000 Q3 | -2.99 Million AUD | 0.0% |
2000 Q1 | -449.2 Thousand AUD | 0.0% |
2000 FY | -5.84 Million AUD | -225.41% |
2000 Q4 | -2.99 Million AUD | 0.0% |
2000 Q2 | -2.99 Million AUD | -565.68% |
1999 FY | -1.79 Million AUD | -151.51% |
1999 Q3 | -449.2 Thousand AUD | 0.0% |
1999 Q4 | -449.2 Thousand AUD | 0.0% |
1999 Q2 | -449.2 Thousand AUD | -151.51% |
1999 Q1 | -178.6 Thousand AUD | 0.0% |
1998 Q4 | -178.6 Thousand AUD | 0.0% |
1998 Q3 | -178.6 Thousand AUD | 0.0% |
1998 FY | -714.42 Thousand AUD | -148.14% |
1998 Q1 | - AUD | 0.0% |
1998 Q2 | -178.6 Thousand AUD | 0.0% |
1997 FY | 1.48 Million AUD | 0.0% |
1997 Q4 | - AUD | 0.0% |
1997 Q2 | - AUD | 0.0% |
1997 Q3 | - AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 74.479% |
Adherium Limited | 267.7 Thousand AUD | -2901.408% |
Aroa Biosurgery Limited | 66.09 Million AUD | 87.844% |
Atomo Diagnostics Limited | 1.6 Million AUD | -400.302% |
Anteris Technologies Ltd | 69.14 Million AUD | 88.381% |
Control Bionics Limited | 9.82 Million AUD | 18.228% |
CardieX Limited | 16.64 Million AUD | 51.74% |
Compumedics Limited | 26.88 Million AUD | 70.108% |
Cochlear Limited | 1.17 Billion AUD | 99.316% |
CleanSpace Holdings Limited | 11.35 Million AUD | 29.266% |
Cyclopharm Limited | 13.38 Million AUD | 39.952% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 37.392% |
Nova Eye Medical Limited | 23.99 Million AUD | 66.507% |
HeraMED Limited | 6.78 Million AUD | -18.457% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 820.073% |
ImpediMed Limited | 28.04 Million AUD | 71.346% |
InhaleRx Limited | 2.59 Million AUD | -210.162% |
LBT Innovations Limited | 1.1 Million AUD | -625.823% |
Micro-X Limited | 18.76 Million AUD | 57.179% |
Neurotech International Limited | 8.75 Million AUD | 8.218% |
OncoSil Medical Limited | 12.03 Million AUD | 33.264% |
PolyNovo Limited | 34.92 Million AUD | 76.992% |
SomnoMed Limited | 58.97 Million AUD | 86.375% |
Universal Biosensors, Inc. | 20 Million AUD | 59.826% |
Uscom Limited | 5.52 Million AUD | -45.558% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 16.596% |